CIAS
WST icon

CBIZ Investment Advisory Services’s West Pharmaceutical WST Stock Holding History

CBIZ Investment Advisory Services’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-52
Closed -$14.3K – 750
2025
Q4 		$14.3K Buy
52
+35
+206% +$9.57K ﹤0.01% 313
2025
Q3 		$4.46K Buy
17
+3
+21% +$729 ﹤0.01% 460
2025
Q2 		$3.06K Buy
+14
New +$2.99K ﹤0.01% 500

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CBIZ Investment Advisory Services's WST Position: Q1 2026 in Review

CBIZ Investment Advisory Services sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 52 shares — an estimated $14.3K sold.

CBIZ Investment Advisory Services first reported a position in WST in Q2 2025 and held it in 3 quarters. The position peaked at $14.3K in Q4 2025. 755 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • CBIZ Investment Advisory Services reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • CBIZ Investment Advisory Services sold 52 West Pharmaceutical shares in Q1 2026, an estimated $14.3K.
  • CBIZ Investment Advisory Services first reported a position in West Pharmaceutical in Q2 2025 and held it in 3 quarters.
  • CBIZ Investment Advisory Services's West Pharmaceutical position peaked at $14.3K in Q4 2025.
  • 755 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on CBIZ Investment Advisory Services's 13F filing for Q1 2026, filed 12 May 2026.